The 10-day RSI Oscillator for HUM moved out of overbought territory on October 13, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 instances where the indicator moved out of the overbought zone. In 22 of the 31 cases the stock moved lower in the days that followed. This puts the odds of a move down at 71%.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HUM as a result. In 48 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for HUM turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 31 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HUM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
HUM broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 34 of 53 cases where HUM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.
HUM moved above its 50-day moving average on October 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HUM crossed bullishly above the 50-day moving average on October 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 76%.
Following a +3.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where HUM advanced for three days, in 218 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 6 (best 1 - 100 worst), indicating outstanding price growth. HUM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.565) is normal, around the industry mean (3.359). P/E Ratio (38.428) is within average values for comparable stocks, (126.681). HUM's Projected Growth (PEG Ratio) (1.304) is slightly higher than the industry average of (0.786). Dividend Yield (0.009) settles around the average of (0.009) among similar stocks. P/S Ratio (0.319) is also within normal values, averaging (0.569).
The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HUM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
OSCR moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend. In 33 of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 89%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 58 cases where OSCR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
Following a +6.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where OSCR advanced for three days, in 231 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
OSCR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 177 of 225 cases where OSCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OSCR as a result. In 62 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for OSCR turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 32 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
The 10-day moving average for OSCR crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OSCR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating fairly steady price growth. OSCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.663) is normal, around the industry mean (3.359). P/E Ratio (19.497) is within average values for comparable stocks, (126.681). OSCR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.618) is also within normal values, averaging (0.569).
HUM | ||
|---|---|---|
OUTLOOK RATING 1..100 | 82 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 91 | |
SMR RATING 1..100 | 98 | |
PRICE GROWTH RATING 1..100 | 6 | |
P/E GROWTH RATING 1..100 | 6 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| HUM | OSCR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 71% | N/A |
| Stochastic ODDS (%) | 1 day ago 64% | 1 day ago 81% |
| Momentum ODDS (%) | 1 day ago 62% | 1 day ago 82% |
| MACD ODDS (%) | 1 day ago 62% | 1 day ago 78% |
| TrendWeek ODDS (%) | 1 day ago 64% | 1 day ago 84% |
| TrendMonth ODDS (%) | 1 day ago 64% | 1 day ago 84% |
| Advances ODDS (%) | 15 days ago 63% | 1 day ago 85% |
| Declines ODDS (%) | 2 days ago 65% | 12 days ago 82% |
| BollingerBands ODDS (%) | 1 day ago 70% | 1 day ago 85% |
| Aroon ODDS (%) | N/A | 1 day ago 79% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HUM’s FA Score shows that 2 FA rating(s) are green while OSCR’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HUM’s TA Score shows that 4 TA indicator(s) are bullish while OSCR’s TA Score has 5 bullish TA indicator(s).
HUM (@Managed Health Care) experienced а +0.94% price change this week, while OSCR (@Managed Health Care) price change was +3.38% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was -0.72%. For the same industry, the average monthly price growth was +6.10%, and the average quarterly price growth was +21.30%.
HUM is expected to report earnings on Nov 06, 2026.
OSCR is expected to report earnings on Nov 05, 2026.
Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
A.I.dvisor indicates that over the last year, HUM has been closely correlated with UNH. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if HUM jumps, then UNH could also see price increases.
A.I.dvisor indicates that over the last year, OSCR has been loosely correlated with CNC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if OSCR jumps, then CNC could also see price increases.
| Ticker / NAME | Correlation To OSCR | 1D Price Change % | ||
|---|---|---|---|---|
| OSCR | 100% | +4.55% | ||
| CNC - OSCR | 49% Loosely correlated | +1.43% | ||
| ELV - OSCR | 42% Loosely correlated | +0.04% | ||
| HUM - OSCR | 39% Loosely correlated | +1.82% | ||
| UNH - OSCR | 37% Loosely correlated | +1.00% | ||
| MOH - OSCR | 35% Loosely correlated | -0.29% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LFGY | 15.24 | 0.69 | +4.74% |
| YieldMax Crypto Industry & Tech Portfolio Option Income ETF | |||
| OWNB | 17.95 | 0.61 | +3.53% |
| Bitwise Bitcoin Standard Corporations ETF | |||
| FMAG | 34.56 | 0.46 | +1.35% |
| Fidelity Magellan ETF (FMAG) | |||
| IUSG | 183.79 | 2.00 | +1.10% |
| iShares Core S&P U.S. Growth ETF (IUSG) | |||
| PTL | 270.19 | 2.11 | +0.79% |
| Inspire 500 ETF (PTL) | |||